Menopause and Your Skin: What Actually Changes, and What Helps

Perimenopause and menopause change skin in three ways most women notice: it gets drier, thinner and less firm. What helps depends on which change bothers you most.

Menopause is 12 months with no period. Perimenopause, the 4 to 8 year transition into it, brings similar symptoms, which is why your skin can change years before anyone uses the word menopause.

What actually changes in your skin during perimenopause and menopause?

Three hormones fall, and all three do something for your skin. Estrogen supports the extracellular matrix (the scaffolding your skin is built on), collagen production and blood supply, and as it decreases, collagen declines with it. Progesterone promotes that same matrix, blood supply and the skin's ability to hold water, and as it falls it affects sebum, the oil your skin makes for itself, and contributes to dryness. Testosterone falls too, which means less blood reaching the skin and less oil, adding to the dryness.

In a global survey of more than 4,300 perimenopausal and postmenopausal women aged 45 to 60, the facial changes reported most often were lines and wrinkles (59%), loss of firmness and elasticity (58%), dryness (56%) and duller tone (40%). A manufacturer sponsored it, so it captures shared experience, not proof that a treatment works.

Why does the change feel so fast?

Collagen in women decreases by about 1% per year beginning in early adulthood, becoming significant by the fifth decade. The slope has been there a long time. What changes in your 40s is that the hormonal support underneath it drops just as the accumulated loss starts showing up in photographs.

Over half the women surveyed learned about menopause's effect on skin by going through it.

Hormones are not the only input: these changes run alongside genetics and sun exposure, and Denver supplies plenty of that.

Do you really lose 30% of your collagen in five years?

Reviews put the loss at about 30% of skin collagen in the first five years of menopause and about 2% a year after that, and the trail ends at a 2013 review article.

The direction is well supported; the size is an estimate repeated for over a decade. The better-anchored number is the 1% a year above: a slope rather than a cliff, and slopes respond to steady work.

Does hormone therapy help your skin?

FDA-approved hormone therapy is approved to relieve hot flashes and night sweats, to treat the vaginal, vulvar and urinary symptoms that come with falling estrogen, and in some products to help prevent osteoporosis. It is not approved for skin: there is no FDA-approved estrogen product with a wrinkle, collagen, firmness or skin-appearance indication. Some women notice their skin feels better on hormone therapy. That is a secondary effect, not the reason it is prescribed.

It is the most effective treatment available for hot flashes and for those vaginal and urinary symptoms, and it can prevent bone loss and fractures. Clinical guidelines do not support prescribing it for skin alone, because the skin-specific trials are not there. Contraindications include unexplained vaginal bleeding, liver disease, a prior estrogen-sensitive cancer, coronary heart disease, stroke, heart attack, or a blood clot in a vein.

Topical estrogen applied to the face is not FDA-approved for anti-aging, and the safety data on how much is absorbed into the body is limited. It is prescribed off-label where a clinician judges it appropriate.

Bioidentical hormone therapy can be prescribed through a compounding pharmacy. A 503A pharmacy makes a preparation for one patient against one prescription, under state board of pharmacy licensure and FDA oversight. A 503B outsourcing facility registers with the FDA and produces under Current Good Manufacturing Practice requirements. Compounding is how a clinician prescribes a strength, a dose or a form no mass-manufactured product offers, or leaves out a preservative a patient reacts to. Your provider prescribes, doses and monitors. The pharmacy fills.

If hot flashes, sleep or vaginal symptoms are part of your picture, bioidentical hormone therapy is worth a conversation. If skin is your only concern, there are treatments aimed directly at it.

Which skin treatments have real evidence behind them?

Three groups are the best supported: topical retinoids, in-office resurfacing, and collagen-stimulating injectables such as poly-L-lactic acid, which stimulates new collagen formation, and intradermal hyaluronic acid. An expert panel named both of those injectables among the interventions it found most effective for hormone-related skin change, which is expert agreement rather than trial data.

Retinoids are considered the gold standard for photo-aged skin. They switch on the cells that make collagen and elastin. Prescription tretinoin (Renova 0.05%) is FDA-approved as an adjunctive agent for the mitigation of fine wrinkles, mottled hyperpigmentation and tactile roughness of facial skin, in patients who also use a comprehensive skin care and sunlight avoidance program. The label states that it does not eliminate wrinkles or reverse photoaging, and that effectiveness has not been established in people over 50 or in people with moderately to heavily pigmented skin. Up to six months may be needed before effects show, and most of the improvement arrives in the first 24 weeks.

Fractora radiofrequency microneedling and the 1540 laser are FDA-cleared. The Fractora applicators are cleared for dermatologic and general surgical procedures for electrocoagulation and hemostasis, with no cleared claim for wrinkles, tightening or collagen, and above 62 millijoules per pin their use is limited to Fitzpatrick skin types I to IV, the lighter end of a standard scale for how skin reacts to sun.

The 1540 fractional non-ablative handpiece is cleared for coagulation of soft tissue, skin resurfacing, and treatment of melasma, striae, acne scars and surgical scars; wrinkles and fine lines belong to the ablative handpiece, which takes off the surface layer of skin rather than heating it through, and to the combined treatment. Using either for menopause-related laxity or crepiness is off-label, which is legal and common.

What both devices do is deliver controlled heat, which prompts new collagen and improves elasticity and texture. Radiofrequency is one of the modalities used for menopausal skin laxity. That is the change these treatments work on: firmness and texture.

What can you do at home?

Moisturizers restore the skin barrier and slow water loss. Menopausal skin is more susceptible to sun injury and to oxidative damage, the same process that browns a cut apple, so pair them with antioxidants and sunscreen.

Retinol is the over-the-counter member of the family and is better tolerated than retinoic acid. Either way, facial redness, peeling and dryness for several weeks are common until the skin adjusts, and that stretch is why a lot of people stop.

Peptide and growth-factor skincare actives have real supporting studies, though formulations vary widely and long-term data is thin. Whether medical-grade skincare is worth the step up is its own question, and peptide therapy is a different subject again.

What to expect at Redbud

The place to start is the change that bothers you most, because dryness, laxity and tone do not respond to the same things. For dryness and dull tone, that usually means skincare and gentle resurfacing, a chemical peel facial or microdermabrasion. For laxity and crepiness, it is Fractora or the 1540 laser, and if the 1540 is the one, what recovery looks like is worth reading first.

These treatments often work together, because each addresses a different part of the change. Nothing gets written down before someone looks at your skin and hears what changed.

If your skin changed and nobody explained why, book a consultation at our Denver office and we will start there.

This article is for education and is not medical advice. Hormone therapy and prescription topicals require an evaluation and a prescription from a licensed clinician. FDA-approved menopausal hormone therapy is approved for hot flashes and night sweats, for vaginal and urinary symptoms of menopause, and in some products for prevention of osteoporosis. It is not approved for a skin or cosmetic indication. Radiofrequency microneedling and the 1540 laser are FDA-cleared devices, and using them for menopause-related skin changes is off-label. A compounded preparation is made by a licensed compounding pharmacy for an individual patient against a prescription, and it is not an FDA-approved product. Regulatory status is current as of September 2026. Results vary.